undamentalytics Newsletter
Sign in

Femasys Inc key statistics and ratios

In fiscal 2025, Femasys Inc had an operating margin of -767.0%, debt equal to 54.2% of equity and a current ratio of 4.53. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Gross margin70.5%68.6%63.4%64.5%66.6%62.0%60.9%
Operating margin−668.0%−706.7%−961.7%<−999%<−999%−767.0%−763.9%
Net margin−666.2%−639.0%−944.6%<−999%<−999%−812.3%−511.8%
Free-cash-flow margin−476.1%−698.3%−923.5%<−999%<−999%−837.9%−786.0%
Return on equity——−54.8%−84.8%−182.2%——
Return on assets−90.9%−41.7%−50.1%−63.8%−93.6%−112.3%−71.3%
Asset turnover0.140.070.050.050.080.140.14
Current ratio1.3415.159.257.590.934.532.14
Debt to equity—0.7%0.9%23.2%234.6%54.2%78.9%
Interest cover (operating income ÷ interest)n/mn/mn/mn/mn/mn/mn/m
R&D as % of revenue398.0%346.2%482.0%672.5%504.4%330.4%280.5%
Capital spending as % of revenue0.8%26.0%33.8%13.4%46.8%22.9%18.4%

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Financial health

2 of 3 checks passed · June 30, 2026
What it owns · $12m
Short-term assets $8mLonger-term assets $4m
What it owes, and who funded it · $12m
Short-term liabilities $4mLonger-term liabilities $4mShareholders' equity $4m
  • Short-term assets cover short-term liabilities $8m of assets due within a year against $4m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $8m short-term assets against $4m of longer-dated liabilities.
  • More cash than debt Cash or debt not separately reported. Not assessable.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
  • Operating profit covers interest at least five times over Operating income of −$18m against $1m of interest.

From Femasys Inc's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Moat

37 /100

Weak moat

How hard Femasys's competitive advantage looks for rivals to wear away, judged from 6 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 0 / 20

    Cash operating profit has been a median -40.4% of total assets over 5 years.

  • Pricing power 19 / 20

    Gross margin has been a median 65.4%, moving by 2.6 percentage points (standard deviation) across 6 years.

  • Durability 10 / 20

    Operating margin has been a median -945.1%; its worst year was -1734.1%.

  • Cash conversion 0 / 20

    Free cash flow was positive in 0 of 6 years, at a median -892.4% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: FEMY vs VNRXFEMY vs ICUFEMY vs IMDX

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Femasys Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Femasys Inc.